Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial

Autor: Mette Kruse Klausen, Mathias Ebbesen Jensen, Marco Møller, Nina Le Dous, Anne-Marie Østergaard Jensen, Victoria Alberte Zeeman, Claas-Frederik Johannsen, Alycia Lee, Gerda Krog Thomsen, Julian Macoveanu, Patrick MacDonald Fisher, Matthew Paul Gillum, Niklas Rye Jørgensen, Marianne Lerbæk Bergmann, Henrik Enghusen Poulsen, Ulrik Becker, Jens Juul Holst, Helene Benveniste, Nora D. Volkow, Sabine Vollstädt-Klein, Kamilla Woznica Miskowiak, Claus Thorn Ekstrøm, Gitte Moos Knudsen, Tina Vilsbøll, Anders Fink-Jensen

Publikováno v: JCI Insight, Vol 7, Iss 19 (2022)

Background Alcohol use disorder (AUD) is a chronic, relapsing brain disorder that accounts for 5% of deaths annually, and there is an urgent need to develop new targets for therapeutic intervention. The glucagon-like peptide-1 (GLP-1) receptor agonis

Externí odkaz: https://doaj.org/article/ae59076593684214ad9ae56a338c5196

Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study

Autor: Claas-Frederik Johannsen, Tonny Studsgaard Petersen, Jimmi Nielsen, Anders Jørgensen, Espen Jimenez-Solem, Anders Fink-Jensen

Publikováno v: Johannsen, C-F, Petersen, T S, Nielsen, J, Jorgensen, A, Jimenez-Solem, E & Fink-Jensen, A 2022, ' Clozapine-and non-clozapine-associated neutropenia in patients with schizophrenia : a retrospective cohort study ', Therapeutic Advances in Psychopharmacology, vol. 12, pp. 1-11 . https://doi.org/10.1177/20451253211072341

Introduction: The antipsychotic drug clozapine remains underutilized partly because of the risk of life-threatening adverse effects, such as neutropenia. Therefore, an extensive hematological monitoring program was set up to detect neutropenia. Metho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::564b18b7c2158055f15526119b91be2f
https://pubmed.ncbi.nlm.nih.gov/35273789